{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:06:06Z","timestamp":1770969966065,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.exer.2010.04.006","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T04:36:13Z","timestamp":1271910973000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bepotastine besilate, a highly selective histamine H1 receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models"],"prefix":"10.1016","volume":"91","author":[{"given":"Tetsuo","family":"Kida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuyo","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2010.04.006_bib1","first-page":"303","article-title":"Current and future topical treatments for ocular allergy","volume":"1","author":"Abelson","year":"2000","journal-title":"Compr. Ophthalmol. Update"},{"key":"10.1016\/j.exer.2010.04.006_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1542-0124(12)70140-4","article-title":"Ocular allergic disease: mechanisms, disease sub-types, treatment","volume":"1","author":"Abelson","year":"2003","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2010.04.006_bib3","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.clinthera.2009.09.001","volume":"31","author":"Abelson","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2006.07.009","article-title":"Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice","volume":"54","author":"Andoh","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2010.04.006_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: ocular allergy","volume":"106","author":"Bielory","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2010.04.006_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2010.04.006_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1398-9995.1997.tb04810.x","article-title":"The eosinophil and the eye","volume":"52","author":"Bonini","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.exer.2010.04.006_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11882-004-0079-0","article-title":"Basic science and pathophysiology of ocular allergy","volume":"4","author":"Calder","year":"2004","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.exer.2010.04.006_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1398-9995.2003.00326.x","article-title":"Animal models of allergic and inflammatory conjunctivitis","volume":"58","author":"Groneberg","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.exer.2010.04.006_bib10","first-page":"879","article-title":"Inhibitory effect of betotastine on anaphylactic and histamine-induced reactions in guinea pigs","volume":"25","author":"Honda","year":"1997","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1248\/bpb.21.411","article-title":"A\u00a0novel anti-allergic drug, betotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells","volume":"21","author":"Kaminuma","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.exer.2010.04.006_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1348-0421.1978.tb00352.x","article-title":"A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats","volume":"22","author":"Katayama","year":"1978","journal-title":"Microbiol. Immunol."},{"issue":"II","key":"10.1016\/j.exer.2010.04.006_bib13","first-page":"1116","article-title":"Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate","volume":"47","author":"Kato","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.exer.2010.04.006_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0952-3278(98)90121-1","article-title":"Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids","volume":"58","author":"Kikuchi","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.exer.2010.04.006_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000183924","article-title":"Downmodulatory effects of the antihistaminic drug bepotastine on cytokine\/chemokine production and CD54 expression in human keratinocytes","volume":"22","author":"Kobayashi","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.exer.2010.04.006_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/jop.2008.0071","article-title":"Comparison of the conjunctival toxicity of topical ocular antiallergic agents","volume":"24","author":"Lee","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","article-title":"Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities","volume":"7","author":"Leonardi","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2010.04.006_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0024-3205(70)90063-9","article-title":"A heat labile mercaptoethanol susceptible homocytotropic antibody in the guinea pig","volume":"9","author":"Mota","year":"1970","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2010.04.006_bib19","first-page":"576","article-title":"Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis","volume":"46","author":"Murata","year":"1997","journal-title":"Jpn. J. Allergol."},{"key":"10.1016\/j.exer.2010.04.006_bib20","first-page":"907","article-title":"General pharmacology of betotastine besilate (TAU-284)","volume":"25","author":"Narita","year":"1997","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1476-5381.1994.tb16182.x","article-title":"Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin","volume":"113","author":"Pettipher","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"II","key":"10.1016\/j.exer.2010.04.006_bib22","first-page":"954","article-title":"Inhibitory effect of betotastine besilate on antigen-induced airway eosinophil infiltration and peripheral blood eosinophilia in mice","volume":"47","author":"Sakai","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.exer.2010.04.006_bib23","first-page":"889","article-title":"Effect of betotastine on experimental asthma induced in guinea pigs","volume":"25","author":"Sakamoto","year":"1997","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/108076803762718132","article-title":"In vitro inhibition of human conjunctival mast-cell degranulation by ketotifen","volume":"19","author":"Schoch","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09273940590909167","article-title":"Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat","volume":"13","author":"Schoch","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2010.04.006_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2307\/2529789","article-title":"A non-parametric equivalent of Williams\u2019 test for contrasting increasing dose levels of a treatment","volume":"33","author":"Shirley","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.exer.2010.04.006_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000110886","article-title":"Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC\/Nga mice","volume":"145","author":"Tanizaki","year":"2008","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.exer.2010.04.006_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000028243","article-title":"Antiallergic action of betotastine besilate (TAU-284) in animal models: a comparison with ketotifen","volume":"57","author":"Ueno","year":"1998","journal-title":"Pharmacology"},{"key":"10.1016\/j.exer.2010.04.006_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jop.1996.12.389","article-title":"The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic\/antihistaminic agent","volume":"12","author":"Yanni","year":"1996","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2010.04.006_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1254\/fpj.110.19","article-title":"Anti-allergic activity of betotastine besilate (TAU-284), a new anti-allergic drug","volume":"110","author":"Yato","year":"1997","journal-title":"Folia Pharmacol. Jpn."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351000117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351000117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:53:13Z","timestamp":1757998393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351000117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S001448351000117X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2010.04.006","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bepotastine besilate, a highly selective histamine H1 receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2010.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}